SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-23-085310
Filing Date
2023-11-09
Accepted
2023-11-09 17:10:24
Documents
53
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0923_oramedphar.htm   iXBRL 10-Q 601549
2 CERTIFICATION f10q0923ex31-1_oramedphar.htm EX-31.1 9353
3 CERTIFICATION f10q0923ex31-2_oramedphar.htm EX-31.2 9349
4 CERTIFICATION f10q0923ex32-1_oramedphar.htm EX-32.1 3553
5 CERTIFICATION f10q0923ex32-2_oramedphar.htm EX-32.2 3455
  Complete submission text file 0001213900-23-085310.txt   3567600

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE ormp-20230930.xsd EX-101.SCH 35297
7 XBRL CALCULATION FILE ormp-20230930_cal.xml EX-101.CAL 39441
8 XBRL DEFINITION FILE ormp-20230930_def.xml EX-101.DEF 176150
9 XBRL LABEL FILE ormp-20230930_lab.xml EX-101.LAB 358568
10 XBRL PRESENTATION FILE ormp-20230930_pre.xml EX-101.PRE 185570
47 EXTRACTED XBRL INSTANCE DOCUMENT f10q0923_oramedphar_htm.xml XML 317320
Mailing Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036
Business Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036 646-844-1164
ORAMED PHARMACEUTICALS INC. (Filer) CIK: 0001176309 (see all company filings)

IRS No.: 980376008 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35813 | Film No.: 231393707
SIC: 2834 Pharmaceutical Preparations